Investors Are Watching: Zynga Inc (NASDAQ:ZNGA), Sequenom Inc. (NASDAQ:SQNM), DCT Industrial Trust Inc. (NYSE:DCT), BIND Therapeutics (NASDAQ:BIND), Orange SA (ADR) (NYSE:ORAN)


On Monday shares of Zynga Inc (NASDAQ:ZNGA) closed at $2.90. Company’s sales growth for last 5 years was 41.50% and EPS growth for next 5 years is recorded as 30.00%. Announced May 07, that Zynga Inc (NASDAQ:ZNGA) founder Mark Pincus is cutting 18 percent of the casual-games company’s work force, less than a month after retaking the reins as chief executive officer.

Sequenom Inc. (NASDAQ:SQNM) in last trading activity fell -2.87% to close at $3.72. Company weekly performance is -20.00% while its quarterly performance stands at 8.77%. Sequenom Inc. (NASDAQ:SQNM) is -12.64% away from its 52 week high. On May 06, Sequenom (NASDAQ:SQNM) reported Q1 EPS of $0.12, which may note compare to the analyst estimate of ($0.03). Revenue for the quarter came in at $37.8 million versus the consensus estimate of $38.6 million.

On last trading day DCT Industrial Trust Inc. (NYSE:DCT) fell -1.78% to close at $33.14. Its volatility for the week is 2.10% while volatility for the month is 1.75%. DCT’s sales growth for past 5 years was 7.70% and its EPS growth for past 5 years was 25.10%. DCT Industrial Trust Inc. (NYSE:DCT) monthly performance is -1.84%.

BIND Therapeutics, Inc. (NASDAQ:BIND) has 1.70% insider ownership while its institutional ownership stands at 39.60%. In last trading activity company’s stock closed at $6.33. Bind Therapeutics Inc. (NASDAQ:BIND) on May 07, reported a loss of $8.3 million in its first quarter. The Cambridge, Massachusetts-based company said it had a loss of 44 cents per share.

On last trading day Orange SA (ADR) (NYSE:ORAN) fell -2.61% to close at $16.07. Its volatility for the week is 1.51% while volatility for the month is 1.22%. ORAN’s sales growth for past 5 years was -2.50% and its EPS growth for past 5 years was -17.50%. Orange SA (ADR) (NYSE:ORAN) monthly performance is -2.01%. Orange SA (NYSE:ORAN) has received a “BBB+” credit rating from analysts at Morningstar. The research firm’s “BBB+” rating indicates that the company is a moderate default risk. They also gave their stock a three star rating.


Leave a Reply

Your email address will not be published. Required fields are marked *